BioRestorative Therapies, Inc. is a life sciences company. The Company develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. It's programs include Disc/Spine Program (brtxDISC) and Metabolic Program (ThermoStem). Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous cultured mesenchymal stem cells collected from the patient’s bone marrow. It is developing BRTX-100 for use for the non-surgical...